In conclusion, we have demonstrated that the GluN2B-specific conantokin, con-G, corrected MCAO-induced neurological deficits, as well as structural changes to the neurons and neuronal cytoarchitecture due to ischemia in the peri-infarct region of the stroked brain. This evidence concerns the gene GRIN2B and ischemia.